Bank of America’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-29,289
| Closed | -$142K | – | 7338 |
|
|
2020
Q1 | $142K | Buy |
29,289
+7,774
| +36% | +$50.4K | ﹤0.01% | 5313 |
|
|
2019
Q4 | $229K | Sell |
21,515
-6,514
| -23% | -$64.7K | ﹤0.01% | 5558 |
|
|
2019
Q3 | $292K | Sell |
28,029
-42,666
| -60% | -$558K | ﹤0.01% | 5426 |
|
|
2019
Q2 | $1.08M | Sell |
70,695
-79,882
| -53% | -$1.16M | ﹤0.01% | 4507 |
|
|
2019
Q1 | $1.94M | Buy |
150,577
+139,908
| +1,311% | +$1.58M | ﹤0.01% | 4017 |
|
|
2018
Q4 | $101K | Buy |
10,669
+3,866
| +57% | +$50.1K | ﹤0.01% | 5914 |
|
|
2018
Q3 | $112K | Sell |
6,803
-13,745
| -67% | -$220K | ﹤0.01% | 5820 |
|
|
2018
Q2 | $329K | Buy |
20,548
+10,159
| +98% | +$181K | ﹤0.01% | 5129 |
|
|
2018
Q1 | $158K | Buy |
10,389
+3,730
| +56% | +$58.1K | ﹤0.01% | 5502 |
|
|
2017
Q4 | $103K | Buy |
6,659
+2,383
| +56% | +$31.9K | ﹤0.01% | 5725 |
|
|
2017
Q3 | $47K | Buy |
4,276
+1,039
| +32% | +$9.77K | ﹤0.01% | 5974 |
|
|
2017
Q2 | $30K | Sell |
3,237
-2,709
| -46% | -$22.6K | ﹤0.01% | 6092 |
|
|
2017
Q1 | $51K | Buy |
5,946
+1,399
| +31% | +$12.8K | ﹤0.01% | 5923 |
|
|
2016
Q4 | $49K | Buy |
4,547
+1,588
| +54% | +$19.2K | ﹤0.01% | 5944 |
|
|
2016
Q3 | $33K | Buy |
2,959
+382
| +15% | +$3.11K | ﹤0.01% | 5910 |
|
|
2016
Q2 | $18K | Sell |
2,577
-20,488
| -89% | -$129K | ﹤0.01% | 6299 |
|
|
2016
Q1 | $107K | Buy |
23,065
+1,149
| +5% | +$5.61K | ﹤0.01% | 5455 |
|
|
2015
Q4 | $138K | Buy |
21,916
+19,779
| +926% | +$161K | ﹤0.01% | 5583 |
|
|
2015
Q3 | $19K | Buy |
2,137
+100
| +5% | +$1.05K | ﹤0.01% | 6328 |
|
|
2015
Q2 | $24K | Buy |
2,037
+367
| +22% | +$5.1K | ﹤0.01% | 6274 |
|
|
2015
Q1 | $24K | Sell |
1,670
-1,224
| -42% | -$18.7K | ﹤0.01% | 5979 |
|
|
2014
Q4 | $49K | Buy |
2,894
+2,602
| +891% | +$37.5K | ﹤0.01% | 6363 |
|
|
2014
Q3 | $3K | Sell |
292
-10,208
| -97% | -$126K | ﹤0.01% | 7718 |
|
|
2014
Q2 | $154K | Buy |
10,500
+10,480
| +52,400% | +$161K | ﹤0.01% | 5783 |
|
|
2014
Q1 | $0 | Sell |
20
-6,409
| -100% | -$156K | ﹤0.01% | 8242 |
|
|
2013
Q4 | $126K | Buy |
6,429
+5,664
| +740% | +$151K | ﹤0.01% | 5960 |
|
|
2013
Q3 | $35K | Sell |
765
-11,184
| -94% | -$365K | ﹤0.01% | 6631 |
|
|
2013
Q2 | $285K | Buy |
+11,949
| New | +$190K | ﹤0.01% | 5273 |
|
Bank of America's STML Position: Q2 2020 in Review
Bank of America sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 29,289 shares — an estimated $142K sold.
Bank of America first reported a position in STML in Q2 2013 and held it in 28 quarters. The position peaked at $1.94M in Q1 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- Bank of America reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- Bank of America sold 29,289 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $142K.
- Bank of America first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and held it in 28 quarters.
- Bank of America's Stemline Therapeutics, Inc. position peaked at $1.94M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on Bank of America's 13F filing for Q2 2020, filed 14 Aug 2020.